All In Biotech

Drug Trial Radar · NCT06121830

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)

A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 3, Therapeutic Confirmatory Clinical Trial to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-erosive Gastroesophageal Reflux Disease

Last checked: Nov 19, 2026Latest source record: Nov 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 324 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

324

Planned (sponsor's estimate)

Start

Aug 31, 2023

Primary completion

Jan 2025

Study completion Mar 2025

Sponsor

Sponsor type
Industry
First posted
Nov 8, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to determine the efficacy and safety of DWP14012 compared to a placebo following a once-daily oral dose of DWP14012 at 20 mg, 40 mg, or placebo for 4 weeks in patients with NERD.

Conditions

  • Non-erosive Reflux Disease
  • Non-Erosive Gastro-Esophageal Reflux Disease
  • Non-Erosive Esophageal Reflux Disease

Interventions

  • DWP14012 20mgDrug

    DWP14012 20mg, tablet, orally, once daily for up to 4 weeks

  • DWP14012 40mgDrug

    DWP14012 40mg, tablet, orally, once daily for up to 4 weeks

  • PlaceboDrug

    Placebo, tablet, orally, once daily for up to 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of heartburn-free days for 4 weeks (daytime/nighttime)Time frame: 4 Weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Wonkwang University Hospital

    Iksan, Jeollabuk-do, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.